Promisingly, we found a combination of FAP-CAR T cells followed by Meso-CAR T cells had a more robust effect with tumor stabilization and even regression observed in some PDAC-bearing mice that translated into greater prolongation of survival. This evidence concerns the gene FAP and neoplasm.